RFC1 and liver cancer: Even if the results of this study suggest that primary liver cancer patients showing RFC1 80AA genotype and low global DNA methylation at the enrolment, are at risk for poorer survival, further validation is required to assess whether this genetic-epigenetic fingerprint may be used as a clinically valuable prognostic tool.